Safety and Tolerability of NCP-IL-22BP mRNA in Advanced Solid Tumors

NCT07562815 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
9
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

West China Hospital